James Parslow
2020
In 2020, James Parslow earned a total compensation of $359.4K as Chief Financial Officer at Xenetic Biosciences, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $38,900 |
|---|---|
| Salary | $285,000 |
| Other | $35,512 |
| Total | $359,412 |
Parslow received $285K in salary, accounting for 79% of the total pay in 2020.
Parslow also received $38.9K in non-equity incentive plan and $35.5K in other compensation.
Rankings
In 2020, James Parslow's compensation ranked 11,794th out of 13,090 executives tracked by ExecPay. In other words, Parslow earned more than 9.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,794 out of 13,090 | 10th |
Division Manufacturing | 5,042 out of 5,620 | 10th |
Major group Chemicals And Allied Products | 2,059 out of 2,253 | 9th |
Industry group Drugs | 1,797 out of 1,953 | 8th |
Industry Pharmaceutical Preparations | 1,335 out of 1,458 | 8th |
Source: SEC filing on October 17, 2022.
Parslow's colleagues
We found two more compensation records of executives who worked with James Parslow at Xenetic Biosciences in 2020.